Fellowship · Columbus, OH
Sponsored by Ohio State University Hospital
Enhanced neutralization resistance of SARS-CoV-2 Omicron subvariants BQ.1, BQ.1.1, BA.4.6, BF.7, and BA.2.75.2.
Cell host & microbe · 2023 · 229 citations · Gerard Lozanski
Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial.
Nature medicine · 2022 · 243 citations · Gerard Lozanski
Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection.
Science translational medicine · 2022 · 191 citations · Gerard Lozanski
Exosomes derived from programmed cell death: mechanism and biological significance.
Cell communication and signaling : CCS · 2024 · 43 citations · Yulan Jin
Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants.
The New England journal of medicine · 2022 · 138 citations · Gerard Lozanski
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.
Blood · 2024 · 45 citations · Weiqiang Zhao,
TRAF6 autophagic degradation by avibirnavirus VP3 inhibits antiviral innate immunity via blocking NFKB/NF-κB activation.
Autophagy · 2022 · 80 citations · Yulan Jin
Neutralization of SARS-CoV-2 Omicron sub-lineages BA.1, BA.1.1, and BA.2.
Cell host & microbe · 2022 · 119 citations · Gerard Lozanski